P38 MAP kinase inhibitors and methods for using the same

Details for Australian Patent Application No. 2006283940 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Durkin, Kieran; Gabriel, Tobias; McCaleb, Kristen Lynn; Arora, Nidhi; Yasuda, Dennis Mitsugu; Billedeau, Roland Joseph; Dewdney, Nolan James; Arzeno, Humberto Bartolome; Soth, Michael

Agent Davies Collison Cave

Pub. Number AU-A-2006283940

PCT Pub. Number WO2007/023110

Priority 60/712,009 25.08.05 US

Filing date 16 August 2006

Wipo publication date 1 March 2007

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/4162 (2006.01) - condensed with heterocyclic ring systems

C07D 231/56 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

28 February 2008 PCT application entered the National Phase

  PCT publication WO2007/023110 Priority application(s): WO2007/023110

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006283941-P38 MAP kinase inhibitors and methods for using the same

2006283935-Fused pyrazole as p38 MAP kinase inhibitors